CME CirclePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

The Importance of Gram-Positive Bacterial Infections in the Hospital Setting CME
Faculty: Richard Wunderink, MD, FACP, FACCP; Marin Kollef, MD; Curtis Sessler, MD; Michael Niederman, MD
Disclosures

Release Date: March 18, 2002; Valid for credit through March 18, 2003

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.


Editorial content produced by Synergy Medical CommunicationsThis CME activity is based on transcripts and slides of presentations as delivered by the faculty at "The Importance of Gram-Positive Bacterial Infections in the Hospital Setting" symposium held at the Philadelphia Marriott in Philadelphia, Pennsylvania on November 6, 2001.

Contents of This CME Activity
  1. Factors Promoting Antibiotic Resistance in the Community and Hospital Setting
    Infection Control Practices
    Antibiotic Selective Pressure Promotes Antibiotic Resistance
    Additional Data on Antibiotic Selective Pressure
    Prolonged Antibiotic Courses
    Inadequate Antibiotic Dose
    Prior Use of Less Effective Drug in the Same Antibiotic Class
    Protected Site or Foreign Bodies
    Other Factors That Promote or Decrease Antibiotic Resistance

  2. New Developments in the Antibiotic Management of Hospital-Acquired Pneumonia
    Antibiotic Resistance: Overview
    A Study of Hospital-Acquired Pneumonia
    Defining Appropriate Timing and Agents for Hospital-Acquired Pneumonia
    Attributable Mortality for Hospital-Acquired Pneumonia
    The Problem of Inadequate Therapy for Hospital-Acquired Pneumonia
    Improving Antibiotic Therapy for Hospital-Acquired Pneumonia: Balancing the Risk of Resistance
    Putting Improved Strategies for Hospital-Acquired Pneumonia to Work: A Study of Patients With Ventilator-Associated Pneumonia
    A Second Study in Patients With Ventilator-Associated Pneumonia: Study Design
    A Second Study in Patients With Ventilator-Associated Pneumonia: Study Findings
    A Second Study in Patients With Ventilator-Associated Pneumonia: Cultures
    Other Strategies to Reduce Hospital-Acquired Pneumonia
    Linezolide

  3. Management and Prevention of Hospital-Acquired Bloodstream Infections
    Nosocomial Bloodstream Infections: Introduction
    Nosocomial Bloodstream Infections: Etiology, Costs, and Pathogens
    Risk Factors for the Development of Nosocomial Bloodstream Infections: Catheter-Related Infections
    Preventing Catheter-Related Infections
    Preventing Catheter-Related Infections: Site Care
    Correlation Between Thrombosis and Catheter-Related Infections
    Antimicrobial-Impregnated Catheters: Do They Make a Difference?
    Cost vs Benefit of Antimicrobial-Impregnated Catheters, Recommendations for Use
    Exchange Strategies: Consensus, Controversies, and Complications
    General Guidelines for Preventing Nosocomial Infections
    General Guidelines for Preventing Nosocomial Infections (Continued)

  4. Optimizing Antibiotic Management of CAP
    American Thoracic Society Guidelines for the Treatment of Community-Acquired Pneumonia: Overview
    Bacteriologic Risk Factors/Treatment Modifiers
    Pneumococcal Resistance and Community-Acquired Pneumonia
    Antibiotic Therapies for Community-Acquired Pneumonia: The Quinolones
    Antibiotic Therapies for Community-Acquired Pneumonia: Linezolid
    Atypical Pathogens in Community-Acquired Pneumonia
    Switching From Intravenous to Oral Therapy
    Community-Acquired Pneumonia: How Are We Doing In Our Antibiotic Choices?

These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape, the CME provider, the companies providing educational grants or the authors and writers. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information and consult a qualified healthcare professional before treating patients or utilizing any therapeutic product discussed in this educational activity.

 
Copyright © 2002 by the American College of Chest Physicians
Pfizer
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.